ANSES opiinion on the development of a chronic TRV by the respiratory route for 1,3-butadiene
On 11 April 2019, ANSES received a formal request from the Directorate General for Health (DGS)
and the Directorate General for Risk Prevention (DGPR) to carry out the following expert appraisal:
formal request on the selection or development of toxicity reference values (TRVs) for 1,3-butadiene.
CONTINUE READING ON www.anses.fr